Teva provides update on generic contraceptive

JERUSALEM Teva Pharmaceutical Industries announced that it is extending its agreement with Ortho-McNeil-Janssen to cease shipment of its generic version of Ortho Tri-Cyclen Lo.

Teva develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80% of Teva's sales are in North America and Europe.